NSE · SURAKSHA
Suraksha Diagnostic Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,239
of 5,004 stocks
🏆 New peak
▲ 401W
Peak #1,239 · 01 Oct 2026
Operating in Healthcare, Suraksha Diagnostic Limited carries a steep earnings multiple that prices in strong future growth, is growing revenue at a solid clip, and is well-owned by domestic institutions (23% DII).
Market Cap
1,850.96 Cr
P/E Ratio
57.51
P/B Ratio
7.60
ROE
12.90%
ROCE
14.70%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 87.65 Cr | 81.41 Cr | 77.69 Cr | 78.73 Cr |
| Net Profit | 12.85 Cr | 6.16 Cr | 7.24 Cr | 8.83 Cr |
| EPS | 2.50 | 1.21 | 1.44 | 1.73 |
| Operating Profit | 20.25 Cr | 13.90 Cr | 13.22 Cr | 14.82 Cr |
Shareholding pattern
Promoter
49.10%
Public
50.90%
PUBLIC BREAKDOWN
FII
13.47%
DII
23.23%
MF (within DII)
20.05%
Individuals
12.14%
Mutual fund holdings
₹328.75
Cr total
6
Schemes
5
Fund Houses
₹328.75 Cr
Total Exposure
Nippon India Mutual Fund₹131.91 Cr (40.1%)
Kotak Mahindra Mutual Fund₹123.16 Cr (37.5%)
Aditya Birla Sun Life Mutual Fund₹66.85 Cr (20.3%)
JM Financial Mutual Fund₹6.81 Cr (2.1%)
Motilal Oswal Mutual Fund₹0.02 Cr (0.0%)
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.